Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
holding | PFE | Common Stock | 120K | Feb 23, 2023 | Direct |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | PFE | Stock Appreciation Rights | Award | $0 | +80.4K | $0.00 | 80.4K | Feb 23, 2023 | Common Stock | 80.4K | $42.30 | Direct | F1 | |
transaction | PFE | Stock Appreciation Rights | Award | $0 | +69.9K | $0.00 | 69.9K | Feb 23, 2023 | Common Stock | 69.9K | $42.30 | Direct | F2 |
Id | Content |
---|---|
F1 | The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. |
F2 | The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant. |